A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

Inc. (NYSE American: PTN) has announced the completion of their Phase 2 clinical trial for an obesity treatment, marking a ...

Yo-yo dieting has significantly increased the risk of kidney disease in those with type 1 diabetes, regardless of body mass index and other traditional risk factors, according to a new study published ...

Type 1 diabetes has long been considered a disease of lean people, but obesity is becoming more common in that group as well ...

Scientist develop new equation for detecting hyperfiltration that incorporates age but not body surface area. Read more!

A businessman died after becoming unwell at home, an inquest opening heard. Kevin Watts, of Lancaster Drive, Stanton Harcourt, died on January 13 this year. An inquest was opened into the ...

Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes. (HealthDay News) — For patients with overweight or obesity and type 2 diabetes ...

Additionally, several other conditions that commonly occur alongside obesity — type 2 diabetes, high cholesterol, and metabolic syndrome — all increase your risk of developing MASH.